As of 2026-09-18, the Relative Valuation of Brooklyn Immunotherapeutics Inc (BTX) is 369.20 USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.73 USD, the upside of Brooklyn Immunotherapeutics Inc based on Relative Valuation is 4129.1%.
The range of the Relative Valuation is 328.67 - 427.36 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.0x - 28.6x | 23.0x |
| Forward P/E multiples | 24.3x - 26.5x | 26.5x |
| Fair Price | 328.67 - 427.36 | 369.20 |
| Upside | 3664.8% - 4795.3% | 4129.1% |
| Date | P/E |
| 2026-09-17 | 0.59 |
| 2026-09-16 | 0.58 |
| 2026-09-15 | 0.57 |
| 2026-09-14 | 0.58 |
| 2026-09-11 | 0.59 |
| 2026-09-10 | 0.59 |
| 2026-09-09 | 0.60 |
| 2026-09-08 | 0.60 |
| 2026-09-04 | 0.60 |
| 2026-09-03 | 0.59 |
| 2026-09-02 | 0.59 |
| 2026-09-01 | 0.60 |
| 2026-08-31 | 0.60 |
| 2026-08-28 | 0.60 |
| 2026-08-27 | 0.61 |
| 2026-08-26 | 0.60 |
| 2026-08-25 | 0.59 |
| 2026-08-24 | 0.59 |
| 2026-08-21 | 0.60 |
| 2026-08-20 | 0.60 |
| 2026-08-19 | 0.59 |
| 2026-08-18 | 0.60 |
| 2026-08-17 | 0.62 |
| 2026-08-14 | 0.61 |
| 2026-08-13 | 0.61 |
| 2026-08-12 | 0.59 |
| 2026-08-11 | 0.58 |
| 2026-08-10 | 0.57 |
| 2026-08-07 | 0.57 |
| 2026-08-06 | 0.56 |
| 2026-08-05 | 0.57 |
| 2026-08-04 | 0.58 |
| 2026-08-03 | 0.55 |
| 2026-07-31 | 0.54 |
| 2026-07-30 | 0.53 |
| 2026-07-29 | 0.51 |
| 2026-07-28 | 0.53 |
| 2026-07-27 | 0.54 |
| 2026-07-24 | 0.55 |
| 2026-07-23 | 0.56 |
| 2026-07-22 | 0.56 |
| 2026-07-21 | 0.56 |
| 2026-07-20 | 0.54 |
| 2026-07-17 | 0.54 |
| 2026-07-16 | 0.54 |
| 2026-07-15 | 0.56 |
| 2026-07-14 | 0.57 |
| 2026-07-13 | 0.56 |
| 2026-07-10 | 0.58 |
| 2026-07-09 | 0.58 |